Gilead Sciences (GILD) EV to EBITDA (2009 - 2026)

Gilead Sciences (GILD) has reported EV to EBITDA for 18 consecutive years, with 14.77 the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, EV to EBITDA fell 127.6% year-over-year to 14.77; the trailing twelve-month figure through Jun 2026 stood at 61.48 (down 473.86% YoY), and the FY2025 full-year result was 14.43, down 77.17% from the prior year.
• EV to EBITDA retreated to 14.77 in Q2 2026 per GILD's latest filing, from 63.95 in the prior quarter.
• Across five years, EV to EBITDA topped out at 351.64 in Q1 2022 and bottomed at 20.01 in Q1 2024.
• Historically, EV to EBITDA has averaged 61.01 across 5 years, with a median of 48.96 in 2022.
• The sharpest annual moves came in 2022 and 2024: EV to EBITDA surged 1247.93% in 2022, then tumbled 134.94% in 2024.
• Over 5 years, EV to EBITDA stood at 44.39 in 2022, then surged by 30.78% to 58.06 in 2023, then decreased by 26.23% to 42.83 in 2024, then surged by 70.18% to 72.89 in 2025, then slumped by 120.27% to 14.77 in 2026.
• According to Business Quant data, EV to EBITDA over the past three periods registered 14.77, 63.95, and 72.89 for Q2 2026, Q1 2026, and Q4 2025 respectively.